In a broader analysis across multiple cancers, high expression of TLK1 or TLK2 was significantly associated with poor prognosis in most of cancer types with wild-type BRCA1 (or low TLK1 associated with good outcome), but this was not seen in tumors with BRCA1 deficiency (Fig. S5). The gene discussed is TLK2; the disease is cancer.